These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. US credit crunch impacts biotech across the globe. Mitchell P Nat Biotechnol; 2008 Apr; 26(4):359-60. PubMed ID: 18391997 [No Abstract] [Full Text] [Related]
50. 2006: a stellar year for financing. Lawrence S Nat Biotechnol; 2007 Feb; 25(2):156. PubMed ID: 17287738 [No Abstract] [Full Text] [Related]
51. A reprise for collaborative financing in biotech. Ransom J Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110 [No Abstract] [Full Text] [Related]
52. Biotech holds its own in Q2. Lawrence S Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634 [No Abstract] [Full Text] [Related]
53. White biotechnology: ready to partner and invest in. Kircher M Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821 [TBL] [Abstract][Full Text] [Related]
54. Increasing number of companies found ineligible for SBIR funding. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384 [No Abstract] [Full Text] [Related]
55. Whither agbiotechnology? Val Giddings L Nat Biotechnol; 2006 Mar; 24(3):274-6. PubMed ID: 16525385 [No Abstract] [Full Text] [Related]
56. Eli Lilly enters venture capital arena. Fletcher L Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830 [No Abstract] [Full Text] [Related]
57. This means war. Nat Biotechnol; 2008 Sep; 26(9):954. PubMed ID: 18779784 [TBL] [Abstract][Full Text] [Related]
58. Another clue to biotech value. Jacobs T Nat Biotechnol; 2003 Jul; 21(7):746. PubMed ID: 12833091 [No Abstract] [Full Text] [Related]